IMMUNOTHERAPY

17/06/2025 10:45 20:00

Poster and Exhibition Hall

Time	Session

10:45 20:00	Novel Antibody Therapeutics: Anti-BCMA.ECD for Personalised Cell Therapy in Multiple Myeloma P-448 EACR25-0072 Gunjan Dagar Poster Presenter India	DLL3-targeting CAR-T cells enhanced by co-deletion of PD1 exhibit better efficacy and persistence in a pre-clinical animal model for small cell lung cancer P-449 EACR25-0102 Hua Zhang Poster Presenter Hong Kong, China	Fishing for new immunotherapy compounds to boost innate-tumor rejection P-450 EACR25-0448 Ana Beatriz Machado Poster Presenter Portugal	Preclinical double humanized CD47/SIRPα mouse model and MC38 cell line expressing human CD47 for efficacy and safety assessment of anti-CD47/SIRPΑ-targeting therapies P-451 EACR25-0518 Fabiane Sonego Poster Presenter France	Development of the in vitro 3D Spheroid High-Throughput Screening Platform for the Development of Immune Checkpoint Inhibitors P-452 EACR25-0586 Michal Rudnik Poster Presenter Switzerland	Integrating the Fasting-Mimicking Diet to Augment Anti-tumor Immunity following Adoptive Cell Transfer in Breast Cancer. P-453 EACR25-0656 Evangelia Pavlou Poster Presenter Italy	ROR1-Specific CAR T-Cells: Advancing Targeted Immunotherapy for Cancer P-454 EACR25-0710 Adrian-Bogdan Tigu Poster Presenter Romania	Improved Adoptive T Cell Therapies for Colorectal Liver Metastases by Stabilization of IFNAR1 on Tumor-Specific T-Cells P-455 EACR25-0726 Andrea Castiglioni Poster Presenter Italy	A Pro-Tumorigenic Cytokine with an Unexpected Anti-Cancer Role: TGFβ Enhances NK cell Immunotherapy for pancreatic cancer P-456 EACR25-0738 Valenzano Giampiero Poster Presenter United Kingdom	Development of a humanized anti-ANXA3 monoclonal antibody for potential treatment of hepatocellular carcinoma P-457 EACR25-0752 IANTO BOSHENG HUANG Poster Presenter Hong Kong, China	Tumor-infiltrating immune cell types predicting recurrence-free survival in melanoma patients receiving adjuvant PD-1 inhibitor therapy P-458 EACR25-0974 Andrea Lad Poster Presenter Hungary	Novel Harnessing of Innate and Adaptive Anti-Cancer Immunity: NLRP3-Inflammasome Activation Facilitates Immune Checkpoint Blockade in the Treatment of Mesenchymal Stage IV Colorectal Cancer P-459 EACR25-1026 Klimpe Luis Poster Presenter Germany	Immunopeptidomics approach for the identification of neoantigens in multiple myeloma P-460 EACR25-1028 Gabriela Anna Zuleger Poster Presenter Germany	Bridging the Gap Between In Vitro and In Vivo: STC-1010 Cancer Vaccine Efficacy in 3D Tumor Spheroids P-461 EACR25-1044 George Alzeeb Poster Presenter France	CAM Assay: An Alternative, 3Rs-compliant, In Vivo Model for the Development of Anticancer Immunotherapies P-462 EACR25-1120 Yan Wang Poster Presenter France	Targeting UMG1, a highly glycosylated cancer specific CD43 epitope, by a Bispecific T-Cell Engager (BTCE) in Malignant Melanoma P-463 EACR25-1140 EMANUELA ALTOMARE Poster Presenter Italy	Exploiting human ALK.CAR-T cell therapy for the treatment of ALK+ small cell lung cancer P-464 EACR25-1142 Monkca Maccagno Poster Presenter Italy	Redirecting cytomegalovirus immunity against pancreas cancer for immunotherapy P-465 EACR25-1156 Tatiana Hurtado de Mendoza Poster Presenter United States	Comparative analysis of neoadjuvant PD1+Lenvatinib versus PD1 alone in the tumour immune microenvironment of melanoma: Correlation of immune profiling with pathological response. P-466 EACR25-1196 Jordan William Conway Poster Presenter Australia	Optimized Timing of CD25-Biased IL-2/JES6 (IL-2/IL-2 mAb Complex) Administration Enhances Antitumor Efficacy of Immune Checkpoint Inhibitors P-466A EACR25-1240 Irfan Baki K Poster Presenter Czech Republic	CD25-Biased IL-2/Anti-IL-2 Complexes Enhance Antigen-Primed CD8⁺ T Cell Expansion, Overcome Treg-Mediated Suppression, and Exhibit Significant Antitumor Activity P-467 EACR25-1288 Petra Weberova Poster Presenter Czech Republic	RALA-PRAME DNA Vaccine: A Novel Immunotherapy for High-Grade Serous Ovarian Carcinoma P-468 EACR25-1428 Chayanika Saha Poster Presenter United Kingdom	Accelerating the Manufacture of γδ T Cells for Allogeneic Cancer Therapies: Integrated Cell Differentiation and Expansion in Bioreactors P-470 EACR25-1528 Miguel de Almeida Fuzeta Poster Presenter Portugal	Blockade of PD-L1 endocytosis by uPAR antagonist peptides to improve cancer immunotherapy P-471 EACR25-1544 Elena Frediani Poster Presenter Italy	Impact of Immune Checkpoint Inhibitors on Recurrence Patterns in Early-Stage NSCLC P-471A EACR25-1554 Sofia Silva Poster Presenter Spain	Targeting solid tumor cell lines of diverse histological origins with nucleolin-specific CAR-T cells - a proof-of-concept P-472 EACR25-1684 Teresa Raquel Abreu Poster Presenter Portugal	Immunization against a mutant p53-derived neoantigen by a personalized oncolytic adenovirus P-473 EACR25-1700 Fred Bunz Poster Presenter United States	IL17A depletion remodels pancreatic tumor matrix and boosts ENO1 vaccine efficacy P-474 EACR25-1822 Giorgia Tiberi Poster Presenter Italy	Generation of versatile tumor target cell lines using the SpyCatcher/SpyTag system P-475 EACR25-1904 Filipa Moraes Poster Presenter Portugal	Development of a faster potency assay for evaluation of immune cell-mediated cytotoxicity in vitro P-484A EACR25-1960 Zhong Yu Poster Presenter	CAPTN-3: A novel platform of conditionally activated T cell and NK cell engagers P-476 EACR25-1964 Hadas Reuveni Poster Presenter Israel	Detecting changes in the tumour microenvironment and in CAR T infiltration following chemotherapeutic priming using intravital imaging P-477 EACR25-2022 Marija Dinevska Poster Presenter Australia	Novel NK Cell Immunotherapy Strategy to Enhance Tumor Killing and Overcome Microenvironment Resistance P-478 EACR25-2174 Paola Vacca Poster Presenter Italy	Neutrophil serine proteases alter IL-18 to a superkine P-479 EACR25-2188 Anne W Poster Presenter Sweden	Unlocking the Potential of Dendritic Cell-Derived Extracellular Vesicles in Targeting Triple-Negative Breast Cancer P-915 EACR25-2224 Sofia Torres Quintas Poster Presenter Portugal	Boosting Melanoma Immunotherapy: Synergizing Nanovaccines with PD-L1 Modulation P-480 EACR25-2430 Margarida Ferreira-Silva Poster Presenter Portugal	Anti-CD19 therapy (Blinatumomab®) as a bridge therapy for hematopoietic stem cell transplantation in pediatric patients with relapsed/refractory B-type acute lymphoblastic leukemia Ph-negative P-481 EACR25-2510 Talita Fernandes Nunes Poster Presenter Brazil	NK Cell Exhaustion in Multiple Myeloma: Pathways to Novel Immunotherapies P-482 EACR25-2554 Jacopo Umberto Verga Poster Presenter Ireland	Accelerating immuno-oncology research with flexible workflows using modular Flex-Fit CyTOF panels P-483 EACR25-2558 Melissa Klug Poster Presenter	RAS(ON) G12C-selective and multi-selective doublet combination overcomes clinical resistance mechanisms to KRAS G12C(OFF) inhibitors and sensitizes to immune checkpoint blockade in preclinical models P-484 EACR25-2588 Cristina Blaj Poster Presenter United States